anmelden
Stoxx Europe 50
5.047,28
PKT
-78,24
PKT
-1,53
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Stoxx Europe 50-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 31.03.26 | Unilever Outperform | Bernstein Research | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | LVMH Moet Hennessy Louis Vuitton Outperform | RBC Capital Markets | |
| 31.03.26 | Hermès (Hermes International) Outperform | RBC Capital Markets | |
| 31.03.26 | Richemont Sector Perform | RBC Capital Markets | |
| 31.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | Unilever Underperform | Jefferies & Company Inc. | |
| 31.03.26 | Unilever Underperform | RBC Capital Markets | |
| 31.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 31.03.26 | Siemens Energy Buy | Deutsche Bank AG | |
| 31.03.26 | Novartis Sell | Goldman Sachs Group Inc. | |
| 31.03.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 31.03.26 | Unilever Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | London Stock Exchange (LSE) Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | ASML NV Overweight | JP Morgan Chase & Co. | |
| 31.03.26 | TotalEnergies Overweight | Barclays Capital | |
| 31.03.26 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 31.03.26 | BP Overweight | Barclays Capital | |
| 31.03.26 | AstraZeneca Overweight | Barclays Capital | |
| 31.03.26 | GSK Underweight | Barclays Capital | |
| 31.03.26 | SAFRAN Overweight | Barclays Capital | |
| 31.03.26 | Airbus Overweight | Barclays Capital | |
| 31.03.26 | Siemens Energy Outperform | Bernstein Research | |
| 31.03.26 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 30.03.26 | Siemens Energy Overweight | JP Morgan Chase & Co. | |
| 30.03.26 | Siemens Energy Buy | Jefferies & Company Inc. | |
| 30.03.26 | Rio Tinto Equal-weight | Morgan Stanley | |
| 30.03.26 | LVMH Moet Hennessy Louis Vuitton Buy | UBS AG | |
| 30.03.26 | Schneider Electric Buy | UBS AG | |
| 30.03.26 | Sanofi Neutral | UBS AG | |
| 30.03.26 | Richemont Buy | UBS AG | |
| 30.03.26 | Hermès (Hermes International) Neutral | UBS AG | |
| 30.03.26 | Novartis Buy | Deutsche Bank AG | |
| 30.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 30.03.26 | Schneider Electric Buy | Deutsche Bank AG | |
| 30.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.03.26 | VINCI Overweight | Barclays Capital | |
| 30.03.26 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.03.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 30.03.26 | GSK Underweight | JP Morgan Chase & Co. |